Hemolytic uremic syndrome (HUS), An up-dated nosological classification;Sindrome uremico hemolitico. Ubicacion nosologica actual

Medicina

Volumn 66, Issue SUPPL. 3, 2006, Pages 2-5

  Repetto, Horacio A ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Associated diseases; Enterohemorrhagic Escherichia coli; HUS; Thrombotic microangiopathy

Indexed keywords

CYCLOSPORIN; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; MEMBRANE COFACTOR PROTEIN; MITOMYCIN; RAPAMYCIN; TACROLIMUS; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; COMPLEMENT FACTOR H; HEMOLYTIC AGENT; SHIGA TOXIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ALGORITHM; ARTICLE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; PATHOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; COMPLEMENT ACTIVATION; GLOMERULONEPHRITIS; GRAFT REJECTION; METABOLISM; PHYSIOLOGY; REVIEW;

ADAM PROTEINS; ALGORITHMS; ANTIGENS, CD46; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; GLOMERULONEPHRITIS; GRAFT REJECTION; HEMOLYTIC AGENTS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SHIGA TOXIN; VON WILLEBRAND FACTOR;

EID: 33845748600     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gasser C, Gautier C, Steck A, Siebenmann RE, Oechslin R. Hämolytisch-urämische syndrome. Bilaterale nierenindennekrosen bei akuten erwobenen hämolytischen anämien. Schweiz Med Wochenschr 1955; 85: 905-9.
2. Royer P, Habib R, Mathieu H. La microangiopathie thrombotique du rein chez l'enfant. J Urol 1959; 65: 169-77.
3. Gianantonio CA, Vitacco M, Mendilaharzu F, Rutty A. The hemolytic-uremic syndrome. J Pediatr 1964; 54: 478-91.
4. Kaplan BS, Drummond KN. The hemolytic uremic syndrome is a syndrome (editorial). N Eng J Med 1978; 298: 964-6.
5. Lopez EL, Gianantonio C, Cleary TG. The hemolytic uremic ayndrome in Argentina, en Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura, ed. Kaplan BS, Trompeter RS, Moake JL. New York, Dekker 1992, pp. 89-96.
6. Koster F, Levin J, Walker L, et al. Hemolytic-uremic syndrome after shigellosis. N Eng J Med 1978; 289: 927-33
7. Karmali MA, Steele BT, Petric M, et al. Sporadic cases of hemolytic-uremic associated with fecal cytotoxin and cytotoxin-producing E. coli. Lancet 1983; 1: 619-20.
8. Karmali MA, Petric M, Lim C, et al. The association between idiopathic hemolytic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775-82.
9. De Cristófano MG, Fayad A, Ferraris J, et al. Síndrome urémico hemolítico de la infancia. Su relación con la presencia de verotoxina libre fecal. Arch Arg Pediatr 1986: 339-42.
10. Novillo A, Voyer L Cravioto R, et al. Hemolytic uremic sindrome associated with fecal cytotoxin and verotoxin neutralizing antibodies. Pediatr Nephrol 1988; 2: 288-90.
11. Lopez EL, Diaz M, Grinstein S, et al. Hemolytic uremic syndrome and diarrea in Argentine children: the role of Shiga like toxins. J Infect Dis 1989; 160: 469-75.
12. Tarr PI, Fouser LS, Stapleton AE, et al. Hemolytic-uremic syndrome in a six-year-old girl after urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N Eng J Med 1996; 335: 635-7.
13. Butani L. Hemolytic uremic syndrome associated with Clostridium difficile colitis. Pediatric Nephrol 2004; 19: 1430.
14. Cavagnaro F, Guzmán C, Harris P. Hemolytic uremic syndrome associated with Entamoeba histolytica intestinal infection. Pediatrc Nephrol 2006; 21: 126-28.
15. Maltezou HC, Kallergi C, Kavazarakis E, et al. Hemolytic-uremic syndrome associated with Coxiella burnetti infection. Pediatr Infect Dis J 2001; 20: 811-2.
16. Badesha PS, Saklayen MG. Hemolytic uremic syndrome as a presenting form of HIV infection. Nephron 1996; 72: 472-5.
17. Albaqali A, Ghuloom A, Al Arrayed AA, et al. Hemolytic uremic syndrome in association with typhoid fever. Am J Kidney Dis 2003; 41: 709-13.
18. Klein PJ, Bulla M, Newman RA, et al. Thomsen Friederichsen antigen in hemolytic-uremic syndrome. Lancet 1977; 2: 1024-5.
19. Novak RW, Martin CR, Orsini EN. Hemolytic-uremic síndrome and T-crypt-antigen exposure by neuramini-dase-producing pneumococci: an emerging problem?. Pediatr Pathol 1983; 1: 409-13.
20. Repetto HA. Epidemic hemolytic-uremic syndrome in children. Nephrology Forum. Kidney Int 1997; 52: 1708-19.
21. Fitzpatrick MM, Walters MDS, Trompeter RS, et al. Atypical (non-diarrhea associated) hemolytic-uremic syndrome in childhood. J Pediatr 1993; 122: 532-7.
22. Kaplan BS, Chesney RW, Drummond KN. Hemolytic uremic syndrome in families. N Eng J Med 1975; 292: 1090-3.
23. Warwicker P, Goodship THJ, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998; 53: 836-44.
24. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, et al. Hetrozygous and homozygous factor H deficiencies associated with hemolytic uremic síndrome or membrano-proliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 2004; 15: 787-95.
25. Dragon-Durey MA, Loirat C, Cloarec MA, et al. Anti-Factor H autoantibodies associated with atypical hemolytic syndrome. J Am Soc Nephrol 2005; 16: 555-63.
26. Sánchez Avalos JC. Microangiopatías trombóticas: SUH/PTT. Medicina (Buenos Aires) 2000; 60: 46-58.
27. Furlan M, Robles R, Galbusera M, et al. Von Willebrandt factor-cleaving proteasein thrombotic thrombocytopenic purpura and in the hemolytic uremic syndrome. N Eng J Med 1998; 339: 1578-84.
28. Tsai HM, Lian ECY. Antibodies to von Willebrandt factor cleaving protease in acute thrombotic thrombocytopenic purpura. N Eng J Med 1998; 339: 1585-94.
29. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Eng J Med 1991; 325: 393-7.